Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$848M |
| 2 |
Tesla
TSLA
|
+$759M |
| 3 |
Home Depot
HD
|
+$653M |
| 4 |
Meta Platforms (Facebook)
META
|
+$567M |
| 5 |
Wells Fargo
WFC
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$409M |
| 3 |
Micron Technology
MU
|
+$379M |
| 4 |
AT&T
T
|
+$372M |
| 5 |
Medtronic
MDT
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.69% |
| 2 | Technology | 14.95% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Consumer Staples | 10.7% |
| 5 | Communication Services | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TDAY
3151
USA Today Co
TDAY
$1.27B
| $532K | ﹤0.01% |
117,923
+78,023
| +196% | +$396K |
|
3152
GraniteShares Gold Shares
BAR
$1.36B
| $530K | ﹤0.01% |
27,600
-13,300
| -33% | -$248K |
|
|
CNVY
3153
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
| $530K | ﹤0.01% |
81,100
+57,700
| +247% | +$381K |
|
3154
First Commonwealth Financial
FCF
$2.18B
| $529K | ﹤0.01% |
34,900
-90,400
| -72% | -$1.47M |
|
3155
DSS Inc
DSS
$5.39M
| $527K | ﹤0.01% |
49,555
-26,670
| -35% | -$256K |
|
3156
Chefs' Warehouse
CHEF
$4.71B
| $525K | ﹤0.01% |
16,100
-12,000
| -43% | -$377K |
|
3157
VanEck Merk Gold Trust
OUNZ
$2.51B
| $525K | ﹤0.01% |
27,900
+8,900
| +47% | +$163K |
|
3158
First Trust Technology AlphaDEX Fund
FXL
$2.53B
| $523K | ﹤0.01% |
+4,500
| New | +$524K |
|
|
SPR
3159
DELISTED
Spirit AeroSystems
SPR
| $523K | ﹤0.01% |
+10,700
| New | +$500K |
|
3160
Astec Industries
ASTE
$1.16B
| $522K | ﹤0.01% |
+12,145
| New | +$675K |
|
3161
Super League Enterprise
SLE
$4.28M
| $522K | ﹤0.01% |
29
+6
| +26% | +$119K |
|
3162
Vista Gold
VGZ
$251M
| $522K | ﹤0.01% |
497,186
+150,869
| +44% | +$124K |
|
|
ADVM
3163
DELISTED
Adverum Biotechnologies
ADVM
| $519K | ﹤0.01% |
39,644
-24,374
| -38% | -$357K |
|
3164
CPS Technologies
CPSH
$75.5M
| $518K | ﹤0.01% |
99,500
-71,300
| -42% | -$244K |
|
3165
Eagle Bancorp
EGBN
$846M
| $518K | ﹤0.01% |
9,086
-434
| -5% | -$25.9K |
|
3166
Bank7 Corp
BSVN
$479M
| $517K | ﹤0.01% |
21,893
-15,107
| -41% | -$365K |
|
3167
CuriosityStream
CURI
$145M
| $517K | ﹤0.01% |
+178,170
| New | +$715K |
|
3168
Franklin Wireless
FKWL
$26.9M
| $516K | ﹤0.01% |
129,500
-107,800
| -45% | -$443K |
|
3169
VSE Corp
VSEC
$5.45B
| $516K | ﹤0.01% |
+11,200
| New | +$558K |
|
|
GHSI
3170
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
| $516K | ﹤0.01% |
44,525
+39,551
| +795% | +$803K |
|
3171
Coca-Cola Europacific Partners
CCEP
$48.3B
| $515K | ﹤0.01% |
+10,600
| New | +$568K |
|
3172
Global X SuperDividend US ETF
DIV
$780M
| $515K | ﹤0.01% |
24,400
-4,900
| -17% | -$101K |
|
|
JXG
3173
JX Luxventure
JXG
| $515K | ﹤0.01% |
244
-6
| -2% | -$7.99K |
|
|
PRTK
3174
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $515K | ﹤0.01% |
173,424
+134,800
| +349% | +$507K |
|
|
ATIP
3175
DELISTED
ATI Physical Therapy, Inc.
ATIP
| $513K | ﹤0.01% |
5,459
-2,883
| -35% | -$367K |
|
Similar funds
Renaissance Technologies's Q1 2022 Portfolio in Review
As of Q1 2022, Renaissance Technologies held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.
- Renaissance Technologies's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
- Renaissance Technologies added most to Tesla in Q1 2022, an estimated $759M increase.
- Renaissance Technologies's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
- Renaissance Technologies fully exited Microsoft in Q1 2022, selling an estimated $786M.
- Renaissance Technologies's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
- Renaissance Technologies opened 822 new positions and closed 650 in Q1 2022.
- Renaissance Technologies's portfolio value rose 6% quarter-over-quarter to $85.2B.
Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.